Medical Device News Magazine

Graphene Nanotubes Revolutionize Protective Film Technology: Ultrathin, Permanently Conductive PSA

A novel conductive PSA exhibits remarkable transparency and maintains stable electrical conductivity throughout its lifespan.. Graphene nanotubes inside adhesives make it possible to reduce the number of layers, improving cost-efficiency of processing. The new set of properties enabled by nanotubes expands PSA’s standard range of applications, encompassing optical films, flexible displays, and more.

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The global market for conductive pressure-sensitive adhesives (PSAs) is forecast to reach $12.5 billion by 2025, driven by wide-ranging applications. To keep growing, the industry has always been on the lookout for solutions for anti-static PSA, without drawbacks such as degradation of conductivity over time, low transparency, or limited flexibility.

OCSiAl’s exceptional graphene nanotube -based solution addresses these issues, ushering in a new era of silicone PSA technology. The user-friendly nanotube dispersion TUBALLTM MATRIX 617 results in excellent electrical conductivity combined with more than 90% transparency in a wide range of peeling-strength PSA films.

The nanotube concentrate can be seamlessly integrated into silicone PSA resins without altering standard mixing processes or equipment. “The recently developed product is a concentrate based on a user-friendly reactive silicone polymer and pre-dispersed TUBALL™ graphene nanotubes specifically designed for silicone PSA systems. It offers an extremely fine quality of nanotube dispersion and is easier to handle in specific applications, notably in a low solid-content systems,” said Ekaterina Gorbunova, Development and Support Leader for Elastomers and Vice President at OCSiAl Group.

Just 0.2% TUBALL™ MATRIX 617 ensures uniform dispersion of conductive particles inside PSA film. This results in a stable surface resistivity of less than 107 Ohm/sq, even after multiple peelings and exposure to high temperatures, which makes it possible to meet strict requirements for stable touch screen operations. In comparison, traditional PSA on conventional polymer primer can only achieve surface resistivity of 1010Ohm/sq, because above this level, it tends to become unstable over time.

The newly developed, permanently conductive silicone PSA formulations reduce the number of layers needed, eliminate the requirement for a primer, and improve cost-efficiency. The outcome is a new generation of fine, flexible, transparent, sensitive films suitable for applications in high demand in electronics, medical devices, the automotive industry, and packaging.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”